See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Natural Disasters
Trade War
Donald Trump
Social Media
Baseball
Stock Markets
Artificial Intelligence
Education
Soccer
Trade
Property
Published • loading... • Updated

Airna keeps fundraising train rolling with $155M Series B

Summary by The Business Journals
In a tough market for venture capital fundraising, Cambridge-based Airna continues to rake in capital, with its latest fundraise topping $150 million.

6 Articles

All
Left
Center
2
Right
1
The Daily NewsThe Daily News
Lean Right

AIRNA Raises Oversubscribed $155 Million Series B Financing to Fund Phase 1/2 Clinical Trial for Alpha-1 Antitrypsin Deficiency and Future Pipeline

CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--Apr 1, 2025-

Read Full Article
The Business JournalsThe Business Journals
Center

Airna keeps fundraising train rolling with $155M Series B

In a tough market for venture capital fundraising, Cambridge-based Airna continues to rake in capital, with its latest fundraise topping $150 million.

·United States
Read Full Article
biopharmadive.combiopharmadive.com
Center

RNA editing biotech Airna adds $155M in funding

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

AIRNA secures $155m to bring RNA-candidate to clinic - Pharmaceutical Technology

The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Read Full Article
FinSMEsFinSMEs

AIRNA Raises $155M in Series B Financing

AIRNA, a Cambridge, MA-based biotech company advancing RNA editing therapeutics, raised $155M in Series B funding. The round was led by Venrock Healthcare Capital Partners and Forbion Growth, with participation from RTW Investments, Nextech Invest, ARCH Venture Partners, Forbion Ventures, ND Capital, and other new and existing investors. Alongside this financing, AIRNA announced the appointment […] The post AIRNA Raises $155M in Series B Financi…

Read Full Article
Endpoints NewsEndpoints News

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring a new form of genetic medicine known as RNA editing into the clinic. But that ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

Similar News Topics

Business

Business

Startups

Startups

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal